Surgery Partners (SGRY) Akcie Kurz

The business model of Surgery Partners Inc centers around providing a comprehensive range of surgical services through its network of ambulatory surgery centers, surgical hospitals, and contract services. With a focus on delivering high-quality, cost-effective care, Surgery Partners Inc aims to meet the needs of patients, physicians, and healthcare facilities. By offering a diverse range of surgical specialties, including orthopedics, gastroenterology, and ophthalmology, Surgery Partners Inc strives to improve patient outcomes and satisfaction. Through its strategic partnerships and operational expertise, the company continues to expand its footprint and strengthen its position within the healthcare industry.

The main competitors of Surgery Partners Inc in the market include Tenet Healthcare Corporation, HCA Healthcare, and UnitedHealth Group.

Surgery Partners Inc is a leading healthcare services company with an extensive history in the industry. Established in 2004, Surgery Partners has since grown to become a prominent player in providing surgical services across the United States. With a focus on delivering high-quality care in a cost-effective manner, the company operates a network of surgical facilities and ancillary services centers. Through strategic partnerships, Surgery Partners offers a range of surgical procedures in various specialties, ensuring access to a wide range of patients in need. With their commitment to exceptional patient care, Surgery Partners Inc has established itself as a trusted name in the healthcare sector.

Surgery Partners Inc has achieved several significant milestones in its history. One notable accomplishment includes the strategic acquisition of National Surgical Healthcare in 2017, which expanded the company's reach and capabilities in the outpatient surgical market. Additionally, Surgery Partners Inc achieved recognition as a leader in ambulatory surgery, providing high-quality healthcare services across multiple states. The company has also demonstrated consistent growth and financial performance, further establishing its position in the healthcare industry. Surgery Partners Inc continues to prioritize patient care and innovation, driving its success and reinforcing its reputation as an esteemed company in the stock market.

Surgery Partners Inc is primarily present in the United States.

Surgery Partners Inc values the highest standards of patient care, innovation, and excellence in healthcare services. With a patient-centric approach, the company strives to provide the most advanced surgical solutions and personalized care. The corporate philosophy revolves around compassionate healthcare delivery, continuous improvement, and ethical practices. Surgery Partners Inc is committed to fostering strong relationships with physicians, patients, and partners, while maintaining a focus on operational efficiency and financial strength. The company's dedication to quality outcomes, cutting-edge technology, and commitment to patient satisfaction embodies its core values and corporate philosophy.

Analytici aktuálně stanovují průměrnou cílovou cenu 18,75 USD pro akcii Surgery Partners (medián: 18,50 USD), tedy +26,3 % vůči poslední ceně. Konsensus vychází z 18 hodnocení analytiků.

Surgery Partners Cílové ceny analytiků 2026

18 analytiků aktuálně hodnotí akcii Surgery Partners: 14 doporučuje koupit, 4 držet a 0 prodat. Pro rok 2026 analytici očekávají u Surgery Partners tržby 3,35 Mld. USD a zisk na akcii 0,40 USD.

Surgery Partners Cílové ceny analytiků 2026

Při aktuálním kurzu se akcie Surgery Partners obchoduje za 13,21 EUR (14,85 USD).

Akcie Surgery Partners (SGRY) je kótována na 4 burzách, mimo jiné: NASDAQ (SGRY), Frankfurt (1SP.F), München (1SP.MU), Düsseldorf (1SP.DU).

Surgery Partners Inc. is a leading healthcare company that focuses on outpatient surgical centers and services for the healthcare industry. The company offers a variety of surgical and diagnostic services delivered on an outpatient basis. Surgery Partners Inc. operates over 180 facilities in 31 states in the USA and provides a wide range of surgical services. The business model of Surgery Partners Inc. is based on the goal of providing its patients with top-quality surgical services and continuous medical care at the highest level. The company has an extensive network of outpatient surgical centers and offers its patients a wide range of surgical and diagnostic services, including general surgery, orthopedics, ophthalmology, neurology, gastroenterology, gynecology, and many others. Surgery Partners Inc. also offers specialized procedures and services such as endoscopic examinations, imaging services, pain therapy, and rehabilitation. The company also operates an extensive diagnostic platform that includes advanced imaging technology and diagnostic procedures such as endoscopy and biopsy. The company also has a focus on the development and utilization of cutting-edge technology in surgery and diagnostics to ensure that patients receive excellent medical care. Surgery Partners Inc. also maintains extensive partnerships with healthcare providers and hospitals to enable better coordinated care. The company collaborates with numerous facilities to meet the needs of patients and provide them with a seamless healthcare experience. These partnerships allow Surgery Partners Inc. to expand its network of facilities and improve its services. Surgery Partners Inc. is also actively involved in research and development, working to develop new procedures and technologies to improve surgical services. The company has a strong team of researchers and physicians who continuously seek new opportunities to enhance surgery and diagnostics, thereby ensuring better healthcare. Overall, the business model of Surgery Partners Inc. is focused on providing top-quality surgical and diagnostic services on an outpatient basis. The company operates an extensive network of surgical facilities and offers a wide range of surgical and diagnostic services to meet the needs of its patients. Through healthcare partnerships and the use of cutting-edge technologies, Surgery Partners Inc. strives to provide better healthcare for its patients.

Tržby očekávané za Surgery Partners činí 3,35 Mld. USD. Tato hodnota je založena na aktuálních finančních údajích a odráží výkonnost společnosti.

Zisk očekávané za Surgery Partners činí 51,10 Mil. USD. Čistý zisk odráží ziskovost společnosti po odečtení všech nákladů.

Poměr ceny k zisku (P/E) Surgery Partners je aktuálně 36,95. Poměr P/E porovnává aktuální cenu akcie se ziskem na akcii a pomáhá investorům posoudit ocenění akcie Surgery Partners.

Poměr ceny k tržbám (P/S) Surgery Partners je aktuálně 0,56. Poměr P/S porovnává tržní kapitalizaci s ročními tržbami a slouží jako metrika ocenění akcie Surgery Partners.

Score kvality pro Surgery Partners je 3/10.

ISIN Surgery Partners je US86881A1007. ISIN (International Securities Identification Number) je celosvětově jedinečný identifikátor cenných papírů.

WKN Surgery Partners je A14YWP. WKN (Wertpapierkennnummer) je šestimístný německý identifikační kód cenného papíru.

Ticker Surgery Partners je SGRY. Symbol tickeru se používá k obchodování akcií Surgery Partners na burze.